Dave Collins is currently the Vice President at Eli Lilly and Company, a position held since 2022. Previously, they contributed to the field of biotechnology at Amgen as a Research Scientist from 1991 to 1998. Dave also worked at Eli Lilly and Company in various roles, including Research Fellow and Sr. Director in multiple departments from 2014 to 2017. They completed a PhD in Biochemistry at the University of Tennessee-Knoxville and a Bachelor of Science in Biology at The College of William and Mary, where they continue their education.
This person is not in any teams
This person is not in any offices